Westhoff M, Freitag L
Medizinische Klinik St. Elisabeth-Hospital Gütersloh-Pneumologie.
Pneumologie. 2001 Mar;55(3):130-4. doi: 10.1055/s-2001-12287.
Dysfunction of airway surfactant is suggested as an important factor contributing to the pathogenesis of bronchoconstriction of patients with asthma. We report the case of a 59-year-old female who had an infect-exacerbation of her asthma complicated by a complete collapse of the left lower lung lobe. Only the local application of 150 mg of bovine surfactant resulted in a complete reexpansion of the lobe. Local therapy with replacement of surfactant may be a promising therapeutic approach in treatment of forms of atelectasis, which depend on a dysfunction or disturbed homeostasis of surfactant.
气道表面活性物质功能障碍被认为是导致哮喘患者支气管收缩发病机制的一个重要因素。我们报告了一例59岁女性患者,其哮喘感染加重并伴有左肺下叶完全萎陷。仅局部应用150毫克牛肺表面活性剂就使该肺叶完全复张。对于依赖表面活性物质功能障碍或内环境稳态紊乱的肺不张形式,用表面活性物质替代进行局部治疗可能是一种有前景的治疗方法。